Lytix Biopharma: Comments on ATLAS-IT-05 - Redeye
Bildkälla: Stockfoto

Lytix Biopharma: Comments on ATLAS-IT-05 - Redeye

Redeye is optimistic about the full results from ATLAS-IT-05. Survival figures are much stronger than we had expected from just the ORR. We discuss what they mean for the company.

Redeye is optimistic about the full results from ATLAS-IT-05. Survival figures are much stronger than we had expected from just the ORR. We discuss what they mean for the company.
Börsvärldens nyhetsbrev